Key statistics
On Wednesday, Moleculin Biotech Inc (MOL1:DEU) closed at 3.36, 9.09% above its 52-week low of 3.08, set on Jul 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.36 |
---|---|
High | 3.36 |
Low | 3.36 |
Bid | 3.24 |
Offer | 3.36 |
Previous close | 3.36 |
Average volume | -- |
---|---|
Shares outstanding | 2.84m |
Free float | 2.74m |
P/E (TTM) | -- |
Market cap | 7.25m USD |
EPS (TTM) | -11.62 USD |
Data delayed at least 15 minutes, as of Jul 24 2024.
More ▼
Press releases
- Moleculin to Host Virtual Acute Myeloid Leukemia KOL Event on October 14, 2024
- Moleculin to Present at Two Upcoming Investor Conferences
- Moleculin Announces Positive In Vivo Efficacy Data of Annamycin in Orthotopic and Experimental Lung Metastatic Models of Sarcoma
- Moleculin Participates in Virtual Investor "What this Means" Segment
- Moleculin Announces First Patients Treated in Phase 2 Clinical Trial of STAT3 Inhibitor in Combination with Radiation for the Treatment of Glioblastoma
- Moleculin to Present at the H.C. Wainwright 26th Annual Global Investment Conference
- Moleculin to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar
- Moleculin Announces Closing of up to $16.5 Million Public Offering
- Moleculin Announces Pricing of up to $16.5 Million Public Offering
- Moleculin Reports Second Quarter 2024 Financial Results and Provides Corporate Update
More ▼